Refractive and Biometric Outcomes in Patients with Retinopathy of Prematurity Treated with Intravitreal Injection of Ranibizumab as Compared with Bevacizumab: A Clinical Study of Correction at Three Years of Age

PURPOSE: To compare refractive and biometric outcomes in patients with type 1 retinopathy of prematurity (ROP) treated with intravitreal injection of ranibizumab (IVR) versus bevacizumab (IVB), at a corrected age of 3 years. METHODS: A retrospective case series compared cycloplegic refractive status...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Ophthalmol
मुख्य लेखकों: Chen, Yen-Chih, Chen, San-Ni, Yang, Benjamin Chi-Lan, Lee, Kun-Hsien, Chuang, Chih-Chun, Cheng, Chieh-Yin
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Hindawi 2018
विषय:
Clinical Study
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5866885/
https://ncbi.nlm.nih.gov/pubmed/29713524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/4565216
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन